Cargando…

Women's Health in Multiple Sclerosis: A Scoping Review

BACKGROUND: Women with multiple sclerosis (MS) may face challenges related to managing reproduction, pregnancy, and menopause while simultaneously managing their disease. The purpose of this scoping review was to map the literature broadly related to topics relevant to women's health in MS to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Lindsay, Ng, Huah Shin, O'Mahony, Julia, Amato, Maria Pia, Cohen, Jeffrey A., Harnegie, Mary Pat, Hellwig, Kerstin, Tintore, Mar, Vukusic, Sandra, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841798/ https://www.ncbi.nlm.nih.gov/pubmed/35173669 http://dx.doi.org/10.3389/fneur.2021.812147

Ejemplares similares

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study
por: Al-Sakran, Lina, et al.
Publicado: (2019)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

Sex effects across the lifespan in women with multiple sclerosis
por: Krysko, Kristen M., et al.
Publicado: (2020)

Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)
por: Kozik, Valeska, et al.
Publicado: (2022)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study
por: Zhang, Tingting, et al.
Publicado: (2017)

The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
por: O’Mahony, Julia, et al.
Publicado: (2022)

Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review
por: Bove, Riley, et al.
Publicado: (2021)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life
por: O’Mahony, Julia, et al.
Publicado: (2023)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS
por: Petrin, Julie, et al.
Publicado: (2023)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey
por: Portaccio, Emilio, et al.
Publicado: (2021)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
por: Marriott, James John, et al.
Publicado: (2023)

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
por: Otero-Romero, Susana, et al.
Publicado: (2023)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Occupational outcomes of people with multiple sclerosis: a scoping review
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2022)

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
por: Hillert, Jan, et al.
Publicado: (2021)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence
por: Genuis, Shelagh K., et al.
Publicado: (2021)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results
por: Ploughman, Michelle, et al.
Publicado: (2014)

Current state of research on acupuncture for the treatment of amyotrophic lateral sclerosis: A scoping review
por: Peng, Siyang, et al.
Publicado: (2022)

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

A surface‐in gradient of thalamic damage evolves in pediatric multiple sclerosis
por: Fadda, Giulia, et al.
Publicado: (2019)

Assessing heterogeneity of treatment effect in multiple sclerosis trials
por: Sormani, Maria Pia, et al.
Publicado: (2023)

Multiple sclerosis in the Middle East and North Africa region
por: Khoury, Samia J, et al.
Publicado: (2020)

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7o67hmjtb7pdrjni5mrdbc7003